This inventor holds 5 USPTO granted patents. Top assignees: Ajinomoto Co., Ltd., Ajinomoto Company Incoporated. Active years: 1987-1989.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Tokohama, JP (1987)
- Kawasaki, JP (1987 - 1988)
- Yokohama, JP (1987 - 1989)
Company Filing History:
Years Active: 1987-1989
Title: Izumi Kumashiro: Innovator in Hypoglycemic Agents
Introduction
Izumi Kumashiro is a notable inventor based in Kawasaki, Japan. He has made significant contributions to the field of hypoglycemic agents, with a focus on phenylalanine derivatives. His innovative work has led to the development of several patents that aim to improve medical treatments.
Latest Patents
Kumashiro holds 5 patents, with his latest inventions focusing on hypoglycemic agents. One of his notable patents is a compound of D-phenylalanine derivative for hypoglycemic use. This compound is represented by a specific general formula, where R¹ is selected from various groups, including hydrogen and alkyl chains. Another significant patent involves phenylalanine derivatives that promote the absorption of medicaments such as insulin. These compounds are not only novel but also have potential therapeutic applications.
Career Highlights
Throughout his career, Kumashiro has worked with prominent companies, including Ajinomoto Co., Ltd. and Ajinomoto Company Incorporated. His experience in these organizations has allowed him to develop and refine his innovative ideas in the pharmaceutical field.
Collaborations
Kumashiro has collaborated with several professionals in his field, including Yoshiko Seto and Koji Fukushima. These collaborations have contributed to the advancement of his research and the successful development of his patents.
Conclusion
Izumi Kumashiro's work in the field of hypoglycemic agents showcases his dedication to innovation and improvement in medical treatments. His contributions through patents and collaborations highlight the importance of research in advancing healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
